首航高科(002665.SZ):股東黃文佳被動減持1.19億股
格隆匯 3 月 19日丨首航高科(002665.SZ)公佈,公司於今日收到股東黃文佳的通知,獲悉黃文佳2020年12月13日被海通證券股份有限公司申請,經上海市金融法院進行違約處置司法拍賣成交的股份,於2021年3月17日在中國證券登記結算有限責任公司深圳分公司完成股份劃轉,過户至競買人上海海通證券資產管理有限公司。
黃文佳質押給海通證券部分公司股份1.19億股,因質押回購違約,該部分質押股份被海通證券進行違約處置司法拍賣完成被被動減持。此次黃文佳被動減持股數為1.19億股,占上市公司總股本4.67%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.